4.6 Review

Barrier function of the nasal mucosa in health and type-2 biased airway diseases

Journal

ALLERGY
Volume 71, Issue 3, Pages 295-307

Publisher

WILEY
DOI: 10.1111/all.12809

Keywords

allergic rhinitis; chronic rhinosinusitis with nasal polyps; eosinophil extracellular traps; immune response; nasal epithelial barrier

Funding

  1. European Commission [260895]
  2. Flemish Scientific Research Board, FWO [1841713N, G.039412N, G.067512N, BOF14/GOA/019, BOF01J01113]
  3. Interuniversity Attraction Poles Program-Belgian State Belgian Science Policy [IAP P7/30]

Ask authors/readers for more resources

The mucosal lining of the upper airways represents the outer surface of the body to the ambient air and its contents and is prepared for it as the first line of defense. Apart from the well-described physical barrier and the mucociliary clearance, a variety of systems, including the airway microbiome, antimicrobial proteins, damage-associated molecular patterns, innate lymphoid cells, epithelial-derived cytokines and chemokines, and finally the adaptive immune system, as well as eosinophils as newly appreciated defense cells form different levels of protection against and response to any possible intruder. Of interest especially for allergic airway disease, mucosal germs might not just elicit a classical Th1/Th17-biased inflammatory response, but may directly induce a type-2 mucosal inflammation. Innovative therapeutic interventions may be possible at different levels also; however, whether modulations of the innate or adaptive immune responses will finally be more successful, and how the correction of the adaptive immune response might impact on the innate side, will be determined in the near future.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available